| 5.5 0.17 (3.19%) | 11-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.8 | 1-year : | 23.94 |
| Resists | First : | 14.39 | Second : | 20.5 |
| Pivot price | 6.09  |
|||
| Supports | First : | 4.51 | Second : | 3.75 |
| MAs | MA(5) : | 5.13 |
MA(20) : | 7.77 |
| MA(100) : | 9.95 |
MA(250) : | 206.56 |
|
| MACD | MACD : | -2.2  |
Signal : | -2.1 |
| %K %D | K(14,3) : | 17.4 |
D(3) : | 8.2 |
| RSI | RSI(14): 35.6 |
|||
| 52-week | High : | 1200 | Low : | 0.51 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HSDT ] has closed above bottom band by 30.5%. Bollinger Bands are 86.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 94 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.72 - 5.74 | 5.74 - 5.77 |
| Low: | 5 - 5.02 | 5.02 - 5.04 |
| Close: | 5.46 - 5.5 | 5.5 - 5.54 |
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Fri, 07 Nov 2025
Solana Company Expands SOL Holdings and Outperforms Staking Benchmarks - MyChesCo
Wed, 05 Nov 2025
Solana Company approves share buyback plan for up to $100 million - theblock.co
Wed, 05 Nov 2025
HSDT - Solana Company Latest Stock News & Market Updates - Stock Titan
Wed, 05 Nov 2025
Solana Company (NASDAQ: HSDT) Releases Investor Update - Toronto Star
Wed, 05 Nov 2025
Solana Company (NASDAQ: HSDT) OKs open-ended buyback of up to $100M in common stock - Stock Titan
Thu, 23 Oct 2025
Solana Company Ramps Up Staking Push With Institutional Validators as Shares Tumble - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | -6 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 4.03e+007 (%) |
| Held by Institutions | 732210 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.379e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 356.89 |
| Profit Margin | 0 % |
| Operating Margin | -7 % |
| Return on Assets (ttm) | 725.5 % |
| Return on Equity (ttm) | -108.4 % |
| Qtrly Rev. Growth | 295000 % |
| Gross Profit (p.s.) | -56.38 |
| Sales Per Share | -707.97 |
| EBITDA (p.s.) | -129204 |
| Qtrly Earnings Growth | -12 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0.01 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0 |
| Dividend | 732490 |
| Forward Dividend | 14500 |
| Dividend Yield | 13318000% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|